Effect of indapamide on left ventricular hypertrophy in hypertension: A meta-analysis

American Journal of Cardiology

Volumn 77, Issue 6, 1996, Pages B17-B19

  Carey, Peter A ^a   Sheridan, Desmond J ^a   De Cordoue, Agnes ^b   Guez, David ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDAPAMIDE;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; META ANALYSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030025926     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89234-X     Document Type: Conference Paper

References (20)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566.
2. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham Study. Ann Intern Med 1970;72:813-822.
3. Cooper R, Simmons BE, Castanar A, Santhanam V, Ghali J, Mar M. Left ventricular hypertrophy is associated with increased mortality independent of ventricular function and the number of coronary arteries severely narrowed. Am J Cardiol 1990;65:441-445.
4. Messerli FH. Antihypertensive therapy: going to the heart of the matter. Circulation 1990;81:1128-1135.
5. Dahlof B. Regression of cardiovascular structural changes - a preventive strategy. Clin Exp Hypertens [A] 1990;A12:877-896.
6. Rials SJ, Wu Y, Ford N, Pauletto FJ, Abramson SV, Rubin AM, Marinchak RA, Kowey PR. Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart. Circulation 1995;91:426-430.
7. Levy D, Salomon M, D'Agostina RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994;90:1786-1793.
8. Tamargo J, Delpon E, Valenzuela C. Treatment of left ventricular hypertrophy in hypertensive patients. Eur Heart J 1993;14(suppl J):102-106.
9. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of Hypertension. Arch Intern Med 1993;153:154-183.
10. Massie BM. Effect of diuretic therapy on hypertensive left ventricular hypertrophy. Eur Heart J 1992;13(suppl G):53-60.
11. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A meta-analysis of 109 treatment studies. Am J Hypertens 1992;5:95-110.
12. Chaffman M, Heel RC, Brodgen RN, Speight TM, Avery GS. Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs 1984; (updated June 1988); 28:189-235.
13. Rowlands DB, Glover DR, Young MA, Stallard TJ, Littler WA. Once daily indapamide in the treatment of the elderly and young hypertensive. Eur J Clin Pharmacol. 1984; 27:397-405.
14. Mace PJE, Littler WA, Glover DR, Rowlands DB, Stallard TJ. Regression of left ventricular hypertrophy in hypertension; comparative effects of three different drugs. J cardiovasc Pharmacol 1985; 7(suppl):S52-S55.
15. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
16. Cochran WG. The combination of estimates from different experiments. Biometrics 1954;10:101-129.
17. Senior R, Imbs JL, Bory M, Amabile G, Denis B, Zannad F, De Luca N, Marchegiano R, Lahiri A, Raftery EB, Guez D, Chic M. Indapamide reduces hypertensive left ventricular hypertrophy: an international multicentre study. J Cardiovasc Pharmacol 1993;22(suppl 6):S106-110.
18. Komajda M, Klimczak K, Boutin B, Brackman F, Guez D, Grosgogeat Y. Effects of indapamide on left ventricular mass and function in systemic hypertension with left ventricular hypertrophy. Am J Cardiol 1990;65(suppl):37H-42H.
19. Contard F, Glukhova M, Marotte F, Narcisse G, Schatz C Swynghedauw B, Guez D, Samuel JL, Rappaport L. Diuretic effects on cardiac hypertrophy in the stroke-prone, spontaneously hypertensive rat. Cardiovasc Res 1993;27:429-434.
20. Herpin D, Demange J. Effect of regression to the mean in serial echocardiographic measurements of left ventricular mass. Quantification and clinical implications. Am J Hypertens 1994;7:824-828.